Drugs / Standard of Care
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03926195 Background | May 2019 → Aug 2020 | ankylosing spondylitis, psoriatic arthritis | Lakefront Biotherapeutics NV | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard of Care | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03926195 ↗ |